NCT07263490Recruiting
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) - Investigating Matching, Biomarkers and Outcomes.
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
The aim of this prospective observational cohort study is to investigate the pathophysiological mechanisms behind and risk of pre-eclampsia in women pregnant after fertility treatment with oocyte donation. The participants are included in of of two cohorts. One includes women pregnant after oocyte donation whereas the other includes women pregnant after IVF treatment with autologous oocytes. Participants will be followed throughout pregnancy with blood samples, blood pressure, clinical controls and ultrasound examinations. Clinical outcomes will be registered post-partum.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 462 (estimated)
- First submitted
- 18 Nov 2025
- Start date
- 21 Oct 2024
- Primary completion date
- 31 Oct 2027
- Lead sponsor
- Copenhagen University Hospital, Hvidovre
- Diseases
- High blood pressure
- NCT number
- NCT07263490
What you commit to
- Study type: Observational
- Planned participants: 462
- From 21 Oct 2024 to the primary completion date, 31 Oct 2027
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous breast cancer
- Present or previous chemotherapy/radiation therapy
- Alcohol/drug abuse
Other illness
- HIV/ hepatitis
- Essential hypertension
- Chronic kidney disease
- Undiagnosed vaginal bleeding
- Unregulated thyroid disease
- Cardiovascular disease
- Present or previous malignant disease
Age
- Age \< 18 years
Other
- BMI \> 35 kg/m2
- Uterine malformations
- Persisting ovarian cysts
- Tumors in hypothalamus, pituitary, thyroid, or adrenal glands.
- Known BRCA 1 or 2 gene
- Breast feeding
- Smoking
Who the study is looking for
- Age \> 18 years
- BMI \< 35 kg/m2
- Normal wet smear within the past three years
- Both nulli- and multiparous
- Singletons and multiple gestations
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Copenhagen Fertility Center Coordinator of this site? Confirm its status | Copenhagen | Denmark | Recruiting |
| Trianglen Fertility Clinic Coordinator of this site? Confirm its status | Hellerup | Denmark | Recruiting |
| Fertility Clinic, Herlev / Gentofte Hospital Coordinator of this site? Confirm its status | Herlev | Denmark | Recruiting |
| Fertility Clinic, Rigshospitalet Coordinator of this site? Confirm its status | København Ø | Denmark | Recruiting |
| Sellmer Klinik Coordinator of this site? Confirm its status | København S | Denmark | Recruiting |
| Aleris Fertility Coordinator of this site? Confirm its status | Søborg | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.